Orange, Calif.-based UCI Health has expanded the inpatient bed capacity of its stem-cell transplant program by 200% after opening the UCI Health — Irvine (Calif.) medical campus in December. The inpatient suites are designed to facilitate customized cell therapy delivery…
Author: Elizabeth Gregerson
Salt Lake City-based Huntsman Cancer Institute at the University of Utah will be the first U.S. academic medical center to manufacture a novel prostate cancer imaging drug, flotufolastat F 18. The drug was developed by Blue Earth Diagnostics and will…
Three U.S. cancer centers have been recognized by Planetree for providing person-centered care. Planetree is a nonprofit aimed at elevating the patient experience and “humanizing” healthcare, according to the organization’s website. It certifies global healthcare organizations across the care continuum…
As part of CMS’ PPS-Exempt Cancer Hospital Quality Reporting Program, the agency collects data on four palliative care-related measures at 11 cancer hospitals. The four measures related to palliative care are: Lower rates are better for all four measures, according…
The University of Cincinnati Cancer Center has tapped David Gius, MD, PhD, as director. Dr. Gius will step into the role July 1. Dr. Gius most recently served as associate cancer center director for translational research and assistant dean for…
Advertisement
In October, Philadelphia-based Fox Chase Cancer Center earned the Association of Community Cancer Centers’ Innovator Award for its ACE care model. Developed and led by Fox Chase nurses, the model was designed to improve efficiency, care coordination and patient outcomes…
New York City-based NYU Langone has tapped Daniel Gomez, MD, as chair of the department of radiation oncology at NYU Grossman School of Medicine. Dr. Gomez joins NYU Langone from New York City-based Memorial Sloan Kettering Cancer Center, where he…
Testing for blood-based DNA markers can help identify which colorectal patients face a higher risk of cancer recurrence of death, according to a study published Feb. 1 in Clinical Epigenetics. The study was led by researchers from Tampa, Fla.-based Moffitt…
More than half of women prefer in-clinic cervical cancer screening compared to home-based self-collection, according to a study published Feb. 6 in JAMA Network Open. Recently endorsed by the American Cancer Society and the U.S. Preventive Services Task Force, oncology…
In November, Charlotte, N.C.-based Advocate Health launched a systemwide clinical trial network. The Advocate Health National Center for Clinical Trials aims to make clinical research part of routine care within the health system’s 69 hospitals, more than 1,000 care sites…